SKYE Annual Operating Profit
-$13.67 M
-$1.57 M-12.93%
01 December 2023
Summary:
As of January 28, 2025, SKYE annual operaing income is -$13.67 million, with the most recent change of -$1.57 million (-12.93%) on December 1, 2023. During the last 3 years, it has fallen by -$7.38 million (-117.39%). SKYE annual operating profit is now -333558.54% below its all-time high of $4100.00, reached on October 1, 2012.SKYE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SKYE Quarterly Operating Profit
-$9.52 M
-$1.12 M-13.29%
01 September 2024
Summary:
As of January 28, 2025, SKYE quarterly operating income is -$9.52 million, with the most recent change of -$1.12 million (-13.29%) on September 1, 2024. Over the past year, it has dropped by -$3.37 million (-54.78%). SKYE quarterly operating profit is now -198481.25% below its all-time high of $4800.00, reached on October 1, 2012.SKYE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SKYE TTM Operating Profit
-$28.17 M
-$6.03 M-27.25%
01 September 2024
Summary:
As of January 28, 2025, SKYE TTM operating income is -$28.17 million, with the most recent change of -$6.03 million (-27.25%) on September 1, 2024. Over the past year, it has dropped by -$11.44 million (-68.42%). SKYE TTM operating profit is now -687087.80% below its all-time high of $4100.00, reached on October 1, 2012.SKYE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SKYE Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.9% | -54.8% | -68.4% |
| 3 y3 years | -117.4% | -225.8% | -145.1% |
| 5 y5 years | -191.3% | -225.8% | -145.1% |
SKYE Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -74.2% | at low | -286.8% | at low | -258.9% | at low |
| 5 y | 5-year | -117.4% | at low | -680.1% | at low | -384.4% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
Skye Bioscience Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.52 M(+13.3%) | -$28.17 M(+27.2%) |
| June 2024 | - | -$8.41 M(+36.6%) | -$22.13 M(+32.4%) |
| Mar 2024 | - | -$6.15 M(+50.6%) | -$16.72 M(+22.3%) |
| Dec 2023 | -$13.67 M(+12.9%) | -$4.09 M(+17.1%) | -$13.67 M(+8.0%) |
| Sept 2023 | - | -$3.49 M(+16.6%) | -$12.66 M(+4.7%) |
| June 2023 | - | -$2.99 M(-3.4%) | -$12.10 M(-1.8%) |
| Mar 2023 | - | -$3.10 M(+0.7%) | -$12.32 M(+1.8%) |
| Dec 2022 | -$12.11 M(+54.3%) | -$3.08 M(+5.3%) | -$12.11 M(+5.4%) |
| Sept 2022 | - | -$2.92 M(-9.2%) | -$11.49 M(+10.6%) |
| June 2022 | - | -$3.22 M(+11.4%) | -$10.39 M(+15.4%) |
| Mar 2022 | - | -$2.89 M(+17.3%) | -$9.00 M(+14.7%) |
| Dec 2021 | -$7.85 M(+24.8%) | -$2.46 M(+35.3%) | -$7.85 M(+17.0%) |
| Sept 2021 | - | -$1.82 M(-0.6%) | -$6.71 M(+4.4%) |
| June 2021 | - | -$1.83 M(+5.3%) | -$6.42 M(+10.5%) |
| Mar 2021 | - | -$1.74 M(+31.7%) | -$5.82 M(-7.5%) |
| Dec 2020 | -$6.29 M(-5.2%) | -$1.32 M(-14.3%) | -$6.29 M(-7.7%) |
| Sept 2020 | - | -$1.54 M(+26.0%) | -$6.81 M(+0.5%) |
| June 2020 | - | -$1.22 M(-44.8%) | -$6.78 M(-7.5%) |
| Mar 2020 | - | -$2.21 M(+19.9%) | -$7.33 M(+10.5%) |
| Dec 2019 | -$6.63 M(+41.3%) | -$1.84 M(+22.6%) | -$6.63 M(+8.7%) |
| Sept 2019 | - | -$1.50 M(-15.1%) | -$6.10 M(+8.1%) |
| June 2019 | - | -$1.77 M(+16.9%) | -$5.65 M(+13.9%) |
| Mar 2019 | - | -$1.52 M(+15.2%) | -$4.96 M(+5.6%) |
| Dec 2018 | -$4.69 M | -$1.32 M(+25.8%) | -$4.69 M(+7.5%) |
| Sept 2018 | - | -$1.05 M(-3.2%) | -$4.36 M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$1.08 M(-13.7%) | -$4.08 M(+9.4%) |
| Mar 2018 | - | -$1.25 M(+26.9%) | -$3.73 M(-3.3%) |
| Dec 2017 | -$3.86 M(-13.7%) | -$986.50 K(+29.5%) | -$3.86 M(+2.0%) |
| Sept 2017 | - | -$761.60 K(+4.2%) | -$3.78 M(-2.4%) |
| June 2017 | - | -$730.90 K(-47.0%) | -$3.88 M(-16.2%) |
| Mar 2017 | - | -$1.38 M(+51.3%) | -$4.63 M(+3.6%) |
| Dec 2016 | -$4.47 M(+3.6%) | -$912.10 K(+6.5%) | -$4.47 M(-5.1%) |
| Sept 2016 | - | -$856.10 K(-42.2%) | -$4.71 M(-0.8%) |
| June 2016 | - | -$1.48 M(+21.4%) | -$4.75 M(+2.7%) |
| Mar 2016 | - | -$1.22 M(+5.7%) | -$4.63 M(+7.2%) |
| Dec 2015 | -$4.32 M(+58.0%) | -$1.15 M(+28.8%) | -$4.32 M(-11.2%) |
| Sept 2015 | - | -$896.30 K(-33.9%) | -$4.86 M(+0.8%) |
| June 2015 | - | -$1.36 M(+49.1%) | -$4.82 M(+39.3%) |
| Mar 2015 | - | -$909.80 K(-46.5%) | -$3.46 M(+34.9%) |
| Dec 2014 | -$2.73 M(>+9900.0%) | -$1.70 M(+98.3%) | -$2.57 M(+195.8%) |
| Sept 2014 | - | -$857.60 K(<-9900.0%) | -$868.10 K(+5394.3%) |
| July 2014 | - | $4100.00(-130.6%) | -$15.80 K(-17.7%) |
| Apr 2014 | - | -$13.40 K(+1016.7%) | -$19.20 K(+772.7%) |
| Jan 2014 | - | -$1200.00(-77.4%) | -$2200.00(-69.4%) |
| Oct 2013 | -$7200.00(-275.6%) | -$5300.00(-857.1%) | -$7200.00(-348.3%) |
| July 2013 | - | $700.00(-80.6%) | $2900.00(+38.1%) |
| Apr 2013 | - | $3600.00(-158.1%) | $2100.00(-200.0%) |
| Jan 2013 | - | -$6200.00(-229.2%) | -$2100.00(-151.2%) |
| Oct 2012 | $4100.00 | $4800.00(-4900.0%) | $4100.00(-685.7%) |
| July 2012 | - | -$100.00(-83.3%) | -$700.00(+16.7%) |
| Apr 2012 | - | -$600.00 | -$600.00 |
FAQ
- What is Skye Bioscience annual operaing income?
- What is the all time high annual operating profit for Skye Bioscience?
- What is Skye Bioscience annual operating profit year-on-year change?
- What is Skye Bioscience quarterly operating income?
- What is the all time high quarterly operating profit for Skye Bioscience?
- What is Skye Bioscience quarterly operating profit year-on-year change?
- What is Skye Bioscience TTM operating income?
- What is the all time high TTM operating profit for Skye Bioscience?
- What is Skye Bioscience TTM operating profit year-on-year change?
What is Skye Bioscience annual operaing income?
The current annual operating profit of SKYE is -$13.67 M
What is the all time high annual operating profit for Skye Bioscience?
Skye Bioscience all-time high annual operaing income is $4100.00
What is Skye Bioscience annual operating profit year-on-year change?
Over the past year, SKYE annual operaing income has changed by -$1.57 M (-12.93%)
What is Skye Bioscience quarterly operating income?
The current quarterly operating profit of SKYE is -$9.52 M
What is the all time high quarterly operating profit for Skye Bioscience?
Skye Bioscience all-time high quarterly operating income is $4800.00
What is Skye Bioscience quarterly operating profit year-on-year change?
Over the past year, SKYE quarterly operating income has changed by -$3.37 M (-54.78%)
What is Skye Bioscience TTM operating income?
The current TTM operating profit of SKYE is -$28.17 M
What is the all time high TTM operating profit for Skye Bioscience?
Skye Bioscience all-time high TTM operating income is $4100.00
What is Skye Bioscience TTM operating profit year-on-year change?
Over the past year, SKYE TTM operating income has changed by -$11.44 M (-68.42%)